Hookipa Pharma (HOOK) Insider Trading & Ownership $0.87 +0.09 (+11.03%) As of 03:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Hookipa Pharma (NASDAQ:HOOK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.30%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$38,380.00Number OfInsiders Selling(Last 3 Years)0 Get HOOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Hookipa Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HOOK Insider Buying and Selling by Quarter Hookipa Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/21/2023Reinhard KanderaCFOBuy700$7.20$5,040.00 8/16/2023Reinhard KanderaCFOBuy800$7.10$5,680.00 7/11/2023Jorn AldagCEOBuy500$8.30$4,150.00 7/7/2023Jorn AldagCEOBuy500$8.10$4,050.00 7/5/2023Jorn AldagCEOBuy500$8.90$4,450.00 7/3/2023Jorn AldagCEOBuy500$8.90$4,450.00 6/30/2023Reinhard KanderaCFOBuy1,200$8.80$10,560.00 (Data available from 1/1/2013 forward) HOOK Insider Trading Activity - Frequently Asked Questions Who is on Hookipa Pharma's Insider Roster? The list of insiders at Hookipa Pharma includes Jorn Aldag, and Reinhard Kandera. Learn more on insiders at HOOK. What percentage of Hookipa Pharma stock is owned by insiders? 3.30% of Hookipa Pharma stock is owned by insiders. Learn more on HOOK's insider holdings. Which Hookipa Pharma insiders have been buying company stock? The following insiders have purchased HOOK shares in the last 24 months: Jorn Aldag ($17,100.00), and Reinhard Kandera ($21,280.00). How much insider buying is happening at Hookipa Pharma? Insiders have purchased a total of 4,700 HOOK shares in the last 24 months for a total of $38,380.00 bought. Hookipa Pharma Key ExecutivesMr. Joern Aldag (Age 60)Pres, CEO & Director Mr. Daniel Pinschewer (Age 44)Founder & Chief Scientific Officer Dr. Reinhard Kandera (Age 50)CFO & Director Mr. Anders Lilja Ph.D. (Age 46)Sr. VP of Technical Devel. Mrs. Nina WaibelCommunications & Investor Relations Mang. More Insider Trading Tools from MarketBeat Related Companies PepGen Insider Buying Rockwell Medical Insider Buying Karyopharm Therapeutics Insider Buying Werewolf Therapeutics Insider Buying NRx Pharmaceuticals Insider Buying Kezar Life Sciences Insider Buying Reviva Pharmaceuticals Insider Buying Marinus Pharmaceuticals Insider Buying FibroGen Insider Buying Cadrenal Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:HOOK) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hookipa Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hookipa Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HOOK Stock Free HOOK Stock Alerts